Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $15.94M | $19.18M | -16.92% |
Operating Income | $-239.44M | $-209.03M | -14.55% |
Net Income | $-102.29M | $-91.05M | -12.34% |
EPS (Basic) | $-2.23 | $-2.31 | +3.46% |
EPS (Diluted) | $-2.23 | $-2.31 | +3.46% |
R&D Expense | $200.57M | $171.86M | +16.71% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.39B | $1.26B | +10.30% |
Current Assets | $1.18B | $1.03B | +14.18% |
Total Liabilities | $344.34M | $407.17M | -15.43% |
Current Liabilities | $174.13M | $177.33M | -1.81% |
Stockholders' Equity | $1.05B | $854.09M | +22.56% |
Cash & Equivalents | $282.13M | $292.76M | -3.63% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-180.33M | $-182.76M | +1.33% |
Investing Cash Flow | $-295.5M | $34.03M | -968.38% |
Financing Cash Flow | $474.49M | $3.03M | +15559.67% |
D&A | $11.07M | $11.01M | +0.54% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1502.5% | -1089.7% | -412.79% |
Net Margin | -641.9% | — | — |
ROE | -9.8% | — | — |
ROA | -7.4% | — | — |
Current Ratio | $6.75 | — | — |
Debt to Equity | $0.329 | — | — |
Other companies in Biotechnology